Genesis Research Group today announced that its EVID AI evidence synthesis platform will be available free of charge through 2026 for approved life sciences organizations and eligible researchers.
LONDON and NEW YORK, May 29, 2026 (GLOBE NEWSWIRE) -- Genesis Global has been named a finalist for two honors at the prestigious 2026 Global Markets Choice Awards, presented by Markets Media magazine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results